BioClinica‘s net income was $924,000, compared to $403,000 for the same period in the prior year.
The company’s income from operations were $1.48m for the second quarter ended 30 June 2011, as compared to $657,000 for the same period in 2010.
For the six months ended 30 June 2011 total revenues was $40.08m, compared to $37.34m for the same period in 2010.
Net income was $1.28m for the six months ended 30 June 2011, as compared to $1.11m for the same period prior year.
For the six months ended 30 June 2011, the company’s income from operations was $2.05m, as compared to $1.82m for the same period in 2010.
BioClinica president and CEO Mark Weinstein said for the quarter they showed growth in the board, including: service revenue, gross margin on service revenue, operating income, net income and earnings per share.
"Since its initial launch we have had 11 new clients involving 24 studies commit to the Trident platform for their IVR/IWR needs," Weinstein said.